PAX7 Rabbit Polyclonal Antibody
PAX7 Polyclonal Antibody |
|||
| ES10905-50ul | ELK Biotech | 50ul | 248.4 EUR |
|
Description: A Rabbit Polyclonal antibody against PAX7 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
PAX7 Rabbit pAb |
|||
| A12740-100ul | Abclonal | 100 ul | 369.6 EUR |
PAX7 Rabbit pAb |
|||
| A12740-200ul | Abclonal | 200 ul | 550.8 EUR |
PAX7 Rabbit pAb |
|||
| A12740-20ul | Abclonal | 20 ul | 219.6 EUR |
PAX7 Rabbit pAb |
|||
| A12740-50ul | Abclonal | 50 ul | 267.6 EUR |
PAX7 Rabbit mAb |
|||
| A4134-100ul | Abclonal | 100 ul | 492 EUR |
PAX7 Rabbit mAb |
|||
| A4134-200ul | Abclonal | 200 ul | 685.2 EUR |
PAX7 Rabbit mAb |
|||
| A4134-20ul | Abclonal | 20 ul | 265.2 EUR |
PAX7 Rabbit mAb |
|||
| A4134-50ul | Abclonal | 50 ul | 344.4 EUR |
PAX7 Rabbit pAb |
|||
| A7335-100ul | Abclonal | 100 ul | 369.6 EUR |
PAX7 Rabbit pAb |
|||
| A7335-200ul | Abclonal | 200 ul | 550.8 EUR |
PAX7 Rabbit pAb |
|||
| A7335-20ul | Abclonal | 20 ul | 219.6 EUR |
PAX7 Rabbit pAb |
|||
| A7335-50ul | Abclonal | 50 ul | 267.6 EUR |
PAX7(PAX7/497) Antibody |
|||
| BNC040497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC040497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC041187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC041187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC050497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC050497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCAP0497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCAP0497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCAP1187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCAP1187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCB0497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCB0497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCB1187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCB1187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCP0497-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), PerCP conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCP1187-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), PerCP conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCR0497-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), RPE conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCR1187-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), RPE conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC940497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC940497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC941187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC941187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCA0497-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), APC conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCA1187-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), APC conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC810497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC810497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC811187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC811187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNUB0497-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Concentration: 0.2mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNUB0497-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Concentration: 0.2mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNUB1187-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Concentration: 0.2mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNUB1187-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Concentration: 0.2mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCH0497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNCH0497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCH1187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNCH1187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC880497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC880497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC881187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC881187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC611187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF660R conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC611187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF660R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC680497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC680497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC681187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC681187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC431187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC431187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC470497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC470497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC471187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC471187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC400497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC400497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC401187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC401187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC430497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC430497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC551187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC551187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC610497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF660R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC610497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF660R conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC800497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC800497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC801187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC801187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC051187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC051187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC701187-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNC701187-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC550497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC550497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC700497-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNC700497-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PAX7 (PAX7/1187) Antibody |
|||
| BNUM1187-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against PAX7 (PAX7/1187), 1mg/mL |
|||
PAX7(PAX7/497) Antibody |
|||
| BNUM0497-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against PAX7(PAX7/497), 1mg/mL |
|||
Anti-PAX7 Rabbit Monoclonal Antibody |
|||
| M00845-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal PAX7 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
|||
PAX7 Antibody |
|||
| 49173-100ul | SAB | 100ul | 399.6 EUR |
PAX7 Antibody |
|||
| 49173-50ul | SAB | 50ul | 286.8 EUR |
PAX7 Antibody |
|||
| 35869-100ul | SAB | 100ul | 302.4 EUR |
PAX7 antibody |
|||
| 10R-1583 | Fitzgerald | 100 ug | 614.4 EUR |
|
Description: Mouse monoclonal PAX7 antibody |
|||
PAX7 Antibody |
|||
| ABD7915 | Lifescience Market | 100 ug | 525.6 EUR |
PAX7 Antibody |
|||
| AF7584 | Affbiotech | 200ul | 540 EUR |
PAX7 Antibody |
|||
| 1-CSB-PA891015 | Cusabio |
|
|
|
Description: A polyclonal antibody against PAX7. Recognizes PAX7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
|||
PAX7 Antibody |
|||
| 1-CSB-PA017493ESR1HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PAX7. Recognizes PAX7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200 |
|||
PAX7 Antibody |
|||
| DF7915 | Affbiotech | 200ul | 420 EUR |
PAX7 Antibody |
|||
| F40690-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
PAX7 Antibody |
|||
| F44080-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
PAX7 Antibody |
|||
| F44080-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
PAX7 Antibody |
|||
| V8883-100UG | NSJ Bioreagents | 100ug | 499 EUR |
|
Description: PAX7 is a transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration. [UniProt] |
|||
PAX7 Antibody |
|||
| V8883-20UG | NSJ Bioreagents | 20ug | 219 EUR |
|
Description: PAX7 is a transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration. [UniProt] |
|||
PAX7 Antibody |
|||
| V8883SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
|
Description: PAX7 is a transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration. [UniProt] |
|||
PAX7 Antibody |
|||
| V2773-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2773-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2773IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2773SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2774-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2774-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2774IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2774SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the Pax family of proteins have been linked to disease and cancer in humans. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V7047-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V7047-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V7047IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V7047SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The Pax gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. Pax-7 is a protein specifically expressed in cultured satellite cell-derived myoblasts. In situ hybridization reveals that Pax-7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding Pax-7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2217-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The PAX gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the PAX family of proteins have been linked to disease and cancer in humans. PAX7 is a protein specifically expressed in cultured satellite cell- derived myoblasts. In situ hybridization reveals that PAX7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding PAX7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2217-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: The PAX gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the PAX family of proteins have been linked to disease and cancer in humans. PAX7 is a protein specifically expressed in cultured satellite cell- derived myoblasts. In situ hybridization reveals that PAX7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding PAX7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
PAX7 Antibody |
|||
| V2217SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: The PAX gene family of nuclear transcription factors is comprised of nine members that function during embryogenesis to regulate the temporal and position-dependent differentiation of cells. In addition, the family is involved in a variety of signal transduction pathways in the adult organism. Mutations in the PAX family of proteins have been linked to disease and cancer in humans. PAX7 is a protein specifically expressed in cultured satellite cell- derived myoblasts. In situ hybridization reveals that PAX7 is also expressed in satellite cells residing in adult muscle. A chromosomal aberration in the gene encoding PAX7 causes rhabdomyosarcoma 2 (RMS2) (also called alveolar rhabdomyosarcoma). |
|||
Polyclonal PAX7 antibody - N-terminal region |
|||
| APR00609G | Leading Biology | 0.05mg | 633.6 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAX7 - N-terminal region. This antibody is tested and proven to work in the following applications: |
|||
PAX7 (Phospho-Ser203) Polyclonal Conjugated Antibody |
|||
| C12949 | SAB | 100ul | 476.4 EUR |
PAX7 Conjugated Antibody |
|||
| C35869 | SAB | 100ul | 476.4 EUR |
PAX7 Conjugated Antibody |
|||
| C49173 | SAB | 100ul | 476.4 EUR |
Anti-PAX7 antibody |
|||
| PAab06173 | Lifescience Market | 100 ug | 494.4 EUR |
anti- PAX7 antibody |
|||
| FNab06173 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against PAX7 |
|||
Anti-PAX7 antibody |
|||
| STJ114613 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The specific function of the paired box 7 gene is unknown but speculated to involve tumor suppression since fusion of this gene with a forkhead domain family member has been associated with alveolar rhabdomyosarcoma. Three transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-PAX7 antibody |
|||
| STJ29474 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The specific function of the paired box 7 gene is unknown but speculated to involve tumor suppression since fusion of this gene with a forkhead domain family member has been associated with alveolar rhabdomyosarcoma. Three transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-PAX7 antibody |
|||
| STJ192063 | St John's Laboratory | 200 µl | 236.4 EUR |
|
Description: Unconjugated Rabbit polyclonal to PAX7 |
|||
Anti-PAX7 Antibody Clone PAX7/497, Unconjugated-20ug |
|||
| 5081-MSM1-P0 | EnQuireBio | 20ug | 279.6 EUR |
Anti-PAX7 Antibody Clone PAX7/497, Unconjugated-100ug |
|||
| 5081-MSM1-P1 | EnQuireBio | 100ug | 513.6 EUR |
Anti-PAX7 Antibody Clone PAX7/1187, Unconjugated-100ug |
|||
| 5081-MSM2-P1 | EnQuireBio | 100ug | 513.6 EUR |
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody, Clone: PAX7/497 |
|||
| AMM01161G | Leading Biology | 7 ml | 580.8 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker). The antibodies are raised in Mouse and are from clone PAX7/497. This antibody is applicable in WB and IHC-F, IF, FC |
|||
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody, Clone: PAX7/1187 |
|||
| AMM01162G | Leading Biology | 7 ml | 580.8 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker). The antibodies are raised in Mouse and are from clone PAX7/1187. This antibody is applicable in IHC |
|||
Rabbit Anti-PAX7 monoclonal antibody, clone TE194-15 |
|||
| CABT-L797 | Creative Diagnostics | 100 ul | 932.4 EUR |
PAX7 siRNA |
|||
| 20-abx927811 | Abbexa |
|
|
PAX7 siRNA |
|||
| 20-abx927812 | Abbexa |
|
|
PAX7 (Phospho-Ser203) Antibody |
|||
| 12949-100ul | SAB | 100ul | 302.4 EUR |
PAX7 (Phospho-Ser203) Antibody |
|||
| 12949-50ul | SAB | 50ul | 224.4 EUR |
PAX7 recombinant monoclonal antibody |
|||
| A5679 | Bimake | 100ul X 3 | 714 EUR |
|
Description: A recombinant monoclonal antibody from rabbit against human PAX7 for WB ,ELISA |
|||
Phospho-PAX7 (Ser203) Antibody |
|||
| AF7084 | Affbiotech | 200ul | 540 EUR |
PAX7 Blocking Peptide |
|||
| AF7584-BP | Affbiotech | 1mg | 234 EUR |
PAX7 cloning plasmid |
|||
| CSB-CL017493HU-10ug | Cusabio | 10ug | 451.2 EUR |
|
Description: A cloning plasmid for the PAX7 gene. |
|||
PAX7 Blocking Peptide |
|||
| DF7915-BP | Affbiotech | 1mg | 234 EUR |
Anti-PAX7 (3F10) |
|||
| YF-MA20382 | Abfrontier | 200 ul | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (3H1) |
|||
| YF-MA14596 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (1G11) |
|||
| YF-MA14597 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (4F8) |
|||
| YF-MA14598 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (2B9) |
|||
| YF-MA14599 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (3F10) |
|||
| YF-MA14600 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-PAX7 (4F5) |
|||
| YF-MA14601 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to PAX7 |
|||
Anti-Pax7 (3C9) |
|||
| YF-MA10660 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to Pax7 |
|||
Anti-Pax7 (1E12) |
|||
| YF-MA10661 | Abfrontier | 100 ug | 435.6 EUR |
|
Description: Mouse monoclonal to Pax7 |
|||
Paired Box 7 (PAX7) Antibody |
|||
| abx340001-100ug | Abbexa | 100 ug | 469.2 EUR |
Paired Box 7 (PAX7) Antibody |
|||
| abx236174-100ug | Abbexa | 100 ug | 610.8 EUR |
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody - With BSA and Azide, Clone: PAX7/1187 |
|||
| AMM01163G | Leading Biology | 0.05mg | 475.2 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone PAX7/1187. This antibody is applicable in IHC |
|||
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody - Without BSA and Azide, Clone: PAX7/1187 |
|||
| AMM01164G | Leading Biology | 0.1mg | 580.8 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone PAX7/1187. This antibody is applicable in IHC |
|||
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody - With BSA and Azide, Clone: PAX7/497 |
|||
| APR14731G | Leading Biology | 0.05mg | 475.2 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone PAX7/497. This antibody is applicable in WB and IHC, FC, IP, E |
|||
Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody - Without BSA and Azide, Clone: PAX7/497 |
|||
| AMM00353G | Leading Biology | 0.1mg | 580.8 EUR |
|
Description: A Monoclonal antibody against Human PAX7 (Rhabdomyosarcoma Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone PAX7/497. This antibody is applicable in WB and IHC-F, IF, FC |
|||
Anti-PAX7 (Rhabdomyosarcoma Marker) Monoclonal Antibody |
|||
| M00845 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Mouse Monoclonal PAX7 (Rhabdomyosarcoma Marker) Antibody. Validated in IF and tested in Chicken, Human, Mouse, Rat, Zebrafish. |
|||
Human PAX7 shRNA Plasmid |
|||
| 20-abx953379 | Abbexa |
|
|
Mouse PAX7 shRNA Plasmid |
|||
| 20-abx971933 | Abbexa |
|
|
PAX7 Rabbit Polyclonal Antibody